A recent actuarial analysis in female BRCA1 and BRCA2 mutation carriers showed that mortality risk by age 70 was greater among BRCA1 mutation carriers than among BRCA2 mutation carriers; and that the major contributing causes of death for both BRCA1 and BRCA2 mutation carriers were breast cancer and ovarian cancer [15]. This evidence concerns the gene BRCA2 and ovarian cancer.